SCHEDULE: BlackRock Amends CVS Health Stake Disclosure, Reports 8.3% Beneficial Ownership
Schedule 13G Amendment
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 8.3% of CVS Health Corporation's common stock as of June 30, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 105,292,588 shares of CVS Health Corporation common stock.
- This represents 8.3% of the total outstanding common shares of CVS Health Corporation.
- BlackRock holds sole voting power over 95,632,723 shares and sole dispositive power over all 105,292,588 shares.
- The filing is an Amendment No. 14 to a Schedule 13G, indicating a passive investment.
- BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of CVS Health Corporation.
- BlackRock's principal business office is located at 50 Hudson Yards, New York, NY 10001.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of a significant passive ownership stake by a major institutional investor, BlackRock, in CVS Health Corporation. While not directly positive or negative about the issuer's performance, the continued large holding by BlackRock can be interpreted as a vote of confidence, contributing to a slightly positive sentiment.
Positives
- BlackRock, a major institutional investor, maintains a significant 8.3% stake in CVS Health Corporation, indicating continued confidence in the company.
- The filing confirms BlackRock's passive investment intent, suggesting stability in its holding rather than an activist stance.
Negatives
- No negative information regarding CVS Health Corporation's operations or financial performance is disclosed in this ownership filing.
Risks
- No specific risks related to CVS Health Corporation's business or operations are detailed in this ownership disclosure.
Industry Context
BlackRock's continued significant stake in CVS Health Corporation reflects ongoing institutional interest in the healthcare and pharmacy retail sector, which is characterized by evolving regulatory landscapes, demographic shifts, and increasing demand for integrated health services.
Comparison to Industry Standards
- BlackRock's 8.3% passive stake in CVS Health Corporation is consistent with its strategy of holding significant, non-controlling positions in large-cap companies across various sectors, similar to its holdings in other major healthcare or retail pharmacy entities like UnitedHealth Group or Walgreens Boots Alliance, where it also typically holds substantial passive stakes.
- The beneficial ownership structure, with sole voting and dispositive power concentrated within BlackRock's various business units, aligns with standard practices for large asset managers managing diverse client portfolios, similar to Vanguard Group or State Street Global Advisors.
Stakeholder Impact
- Shareholders: Provides transparency regarding a major institutional investor's significant ownership stake, which can influence market perception and stability.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of previous Power of Attorney revoked by the new one. |
| 2025-01-21 | Date of the new Power of Attorney executed by BlackRock, Inc. |
| 2025-06-30 | Date of event which requires filing of this statement (ownership snapshot date). |
| 2025-07-16 | Date of filing of this Schedule 13G Amendment No. 14. |
Keywords
BlackRock, CVS Health Corporation, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, Healthcare, Pharmacy, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.